Now viewing a bundle in: CE Catalog
How to Survive a DEA Inspection Part 3 & 4 (On Demand Bundle)
Published by International Academy of Compounding Pharmacists



Summary
Register for Due Diligences of a Pharmacy & Compounding Controlled Substances together and save $5!

Programs Included in this Bundle
  1. How to Survive a DEA Inspection Series: Due Diligences of a Pharmacy
    Part Three of a Four-Part Series.

    Today’s pharmacy staff, including pharmacists and pharmacy technicians, will need to familiarize themselves with the stringent laws and regulations enforced by the Drug Enforcement Administration (DEA) through the Office of Diversion Control (Diversion). The focus of any DEA investigation is the legitimacy of a prescription and therefore its targets are the prescriber and the pharmacy that fulfilled the prescription.

    The need to comply with a strict Due Diligence Pharmacy Policy is essential for pharmacists and pharmacy technicians. It is important to protect the pharmacy from being the target of a DEA investigation by knowing what to look for in order to comply.

    Attendees will familiarize themselves with DEA regulations for controlled substances dispensed in a pharmacy setting and the criteria for developing a Due Diligence Policy in order to comply with laws and regulations.

    Accreditation Information:
    This lesson is a knowledge-based CE activity and is targeted to pharmacists and technicians.

    ACPE logo The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this program for 1.0 contact hours (0.1 CEUs) of continuing education credit for pharmacists and technicians. ACPE UAN 0201-9999-15-133-H03-P, 0201-9999-15-133-H03-T.

    If you are interested in earning credit for this program, please note that you will be asked to enter your NABP e-Profile ID during the credit selection step of the registration process. If you have not yet registered your NABP e-Profile ID, please visit www.nabp.net.

    Learning Objectives:
    At the conclusion of this program, the pharmacist and technician attendee will be able to:

    • Review federal criminal actions that can be imposed on a pharmacist when fraud and diversion of prescriptions for Schedules II through V controlled substances are detected through an investigation.
    • Identify the responsibilities and actions of the Drug Enforcement Administration (DEA) through its Office of Diversion Control (Diversion) personnel to enforce federal laws and DEA regulations on the dispensing of controlled substance by means of a prescription.
    • Discuss the steps that a pharmacist can take to determine the legitimacy of a prescription and when the pharmacist would need to discuss the necessity for the prescription and the individual treatment plan leading to the prescribing of a narcotic as part of a patient’s care.
    • Discuss the role of the pharmacist and responsibilities to develop and enforce a Due Diligence Policy in a pharmacy to prevent fraud or diversion of controlled substances obtained through a prescription.
    • Discuss RED FLAG indicators for prescriptions written by a physician that may not be for a legitimate medical purpose.


    This seminar includes the following components:
    • How to Survive a DEA Inspection Series: Due Diligences of a Pharmacy - Video
    • How to Survive a DEA Inspection Series: Due Diligences of a Pharmacy - Audio
    • How to Survive a DEA Inspection Series: Due Diligences of a Pharmacy - Paper

    Credit
     Click on jurisdiction for specific details  


  2. How to Survive a DEA Inspection Series: Compounding Controlled Substances
    Part Four of a Four-Part Series.

    The responsibilities to enforced federal laws and regulations on the compounding of controlled substances by a pharmacy are placed on the Drug Enforcement Administration (DEA) through their Office of Diversion Control (Diversion).

    Since the focus of any DEA compliance inspection is record-keeping, a compounding pharmacy will need to be prepared for that unannounced inspection that will focus on the purpose for compounding medications containing controlled substances and records required by DEA to be maintained by the pharmacy.

    Attendees will familiarize themselves with the types of actions taken by DEA Diversion personnel at a compounding pharmacy. The focus of any compounding pharmacy is whether the pharmacy is compounding for a specific patient or group of patients needing a medication or the manufacturing of a controlled substance medication.

    Accreditation Information:
    This lesson is a knowledge-based CE activity and is targeted to pharmacists and technicians.

    ACPE logo The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this program for 1.0 contact hours (0.1 CEUs) of continuing education credit for pharmacists and technicians. ACPE UAN 0201-9999-15-133-H03-P, 0201-9999-15-133-H03-T.

    If you are interested in earning credit for this program, please note that you will be asked to enter your NABP e-Profile ID during the credit selection step of the registration process. If you have not yet registered your NABP e-Profile ID, please visit www.nabp.net.

    Learning Objectives:
    At the conclusion of this program, the pharmacist and technician attendee will be able to:

    • Identify the authority of Drug Enforcement Administration (DEA) Office of Diversion Control (Diversion) personnel to conduct an unannounced inspection at a compounding pharmacy and records that will be inspected or copied by their personnel.
    • Discuss administrative or civil actions taken by DEA for failure of a pharmacy to maintain compounding records for Schedules II through V prescriptions filled or compounded by the pharmacy.
    • Identify DEA record-keeping violations pertaining to: Inventory of Controlled Substances, Batch Records, Power of Attorney forms and other records required to be maintained by the compounding pharmacy.
    • Discuss the failure of specific DEA Diversion offices to understand the difference between anticipatory compounding versus manufacturing and how a compounding pharmacy can handle such issue when DEA enters the pharmacy.


    This seminar includes the following components:
    • How to Survive a DEA Inspection Series: Compounding Controlled Substances - Video
    • How to Survive a DEA Inspection Series: Compounding Controlled Substances - Paper
    • How to Survive a DEA Inspection Series: Compounding Controlled Substances - Audio

    Credit
     Click on jurisdiction for specific details  



Refund Policy
SeminarWeb and International Academy of Compounding Pharmacists programs are non-refundable.

Privacy Statement
We respect and are committed to protecting your privacy. (Read Statement)


Powered by
Powered by SeminarWeb.com